Carvedilol in the treatment of portal hypertension
Variceal bleeding is a major event in the natural history of end-stage liver disease with a subsequent high mortality rate. Non-selective β-blockers are currently the drugs of choice for preventing first variceal bleeding. Endoscopic rubber band ligation of high risk varices features as a first line...
Main Author: | Hamdan Al-Ghamdi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=2;spage=155;epage=158;aulast=Al-Ghamdi |
Similar Items
-
Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis
by: Tian S, et al.
Published: (2019-01-01) -
Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension
by: Wei Z, et al.
Published: (2018-12-01) -
Research advances in role of carvedilol in management of cirrhotic portal hypertension: a review of clinical trials
by: YANG Chunjiao
Published: (2015-03-01) -
Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding
by: Natalie Funakoshi, et al.
Published: (2012-05-01) -
Rupture of esophageal varices due to portal hypertension
by: Yusri Dianne Jurnalis, et al.
Published: (2010-10-01)